Morgan Stanley’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.45M | Sell |
|
|||||
|
2022
Q3 | $6.5M | Buy |
|
|||||
|
2022
Q2 | $3M | Buy |
|
|||||
|
2022
Q1 | $229K | Sell |
|
|||||
|
2021
Q4 | $878K | Buy |
|
|||||
|
2021
Q3 | $651K | Sell |
|
|||||
|
2021
Q2 | $1.41M | Buy |
|
|||||
|
2021
Q1 | $222K | Sell |
|
|||||
|
2020
Q4 | $580K | Buy |
|
|||||
|
2020
Q3 | $250K | Sell |
|
|||||
|
2020
Q2 | $269K | Buy |
|
|||||
|
2020
Q1 | $154K | Sell |
|
|||||
|
2019
Q4 | $569K | Sell |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q2 | $233K | Buy |
|
|||||
|
2019
Q1 | $156K | Sell |
|
|||||
|
2018
Q4 | $469K | Sell |
|
|||||
|
2018
Q3 | $1.58M | Buy |
|
|||||
|
2018
Q2 | $1.38M | Sell |
|
|||||
|
2018
Q1 | $2.06M | Sell |
|
|||||
|
2017
Q4 | $4.87M | Buy |
|
|||||
|
2017
Q3 | $1.08M | Sell |
|
|||||
|
2017
Q2 | $1.17M | Buy |
|
|||||
|
2017
Q1 | $779K | Sell |
|
|||||
|
2016
Q4 | $1.34M | Buy |
|
|||||
|
2016
Q3 | $985K | Sell |
|
|||||
|
2016
Q2 | $1.73M | Sell |
|
|||||
|
2016
Q1 | $3.68M | Buy |
|
|||||
|
2015
Q4 | $3.39M | Sell |
|
|||||
|
2015
Q3 | $6.95M | Buy |
|
|||||
|
2015
Q2 | $134K | Sell |
|
|||||
|
2015
Q1 | $220K | Buy |
|
|||||
|
2014
Q4 | $43K | Hold |
|
|||||
|
2014
Q3 | $41K | Sell |
|
|||||
|
2014
Q2 | $111K | Sell |
|
|||||
|
2014
Q1 | $861K | Buy |
|